3-tyr-octreotide has been researched along with Inappropriate GH Secretion Syndrome (Acromegaly) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, X | 1 |
| Candrina, R | 1 |
2 other study(ies) available for 3-tyr-octreotide and Inappropriate GH Secretion Syndrome (Acromegaly)
| Article | Year |
|---|---|
[Preliminary study on the relation between serum growth hormone and 1,25-dihydroxyvitamin D3 in acromegalic patients].
Topics: Acromegaly; Adult; Calcifediol; Female; Growth Hormone; Humans; Male; Middle Aged; Octreotide | 1992 |
Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administration.
Topics: Acromegaly; Adenoma; Adult; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Prognosis; Thyrotropin-Releasing Hormone | 1991 |